Demetrios P. Papahadjopoulos
#82,977
Most Influential Person Now
Demetrios P. Papahadjopoulos's AcademicInfluence.com Rankings
Demetrios P. Papahadjopoulosphilosophy Degrees
Philosophy
#2915
World Rank
#4834
Historical Rank
Logic
#852
World Rank
#1406
Historical Rank
Demetrios P. Papahadjopoulosbiology Degrees
Biology
#3480
World Rank
#5318
Historical Rank
Biochemistry
#332
World Rank
#402
Historical Rank
Download Badge
Philosophy Biology
Why Is Demetrios P. Papahadjopoulos Influential?
(Suggest an Edit or Addition)Demetrios P. Papahadjopoulos's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. (1978) (2079)
- Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. (1991) (1550)
- Comparative properties and methods of preparation of lipid vesicles (liposomes). (1980) (1390)
- Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. (1999) (1287)
- Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. (1988) (1094)
- Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes. (1979) (1056)
- Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. (1994) (954)
- Phase transitions in phospholipid vesicles. Fluorescence polarization and permeability measurements concerning the effect of temperature and cholesterol. (1973) (938)
- Phase transitions and phase separations in phospholipid membranes induced by changes in temperature, pH, and concentration of bivalent cations. (1975) (685)
- Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery. (2002) (629)
- Phospholipid model membranes. I. Structural characteristics of hydrated liquid crystals. (1967) (558)
- Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times. (1991) (546)
- Effects of phospholipid acyl chain fluidity, phase transitions, and cholesterol on (Na+ + K+)-stimulated adenosine triphosphatase. (1974) (478)
- Cochleate lipid cylinders: formation by fusion of unilamellar lipid vesicles. (1975) (476)
- Preparation of unilamellar liposomes of intermediate size (0.1-0.2 mumol) by a combination of reverse phase evaporation and extrusion through polycarbonate membranes. (1980) (464)
- Studies on the mechanism of membrane fusion: evidence for an intermembrane Ca2+-phospholipid complex, synergism with Mg2+, and inhibition by spectrin. (1979) (448)
- Studies on the mechanism of membrane fusion: kinetics of calcium ion induced fusion of phosphatidylserine vesicles followed by a new assay for mixing of aqueous vesicle contents. (1980) (443)
- Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro. (1997) (432)
- Surface properties of acidic phospholipids: interaction of monolayers and hydrated liquid crystals with uni- and bi-valent metal ions. (1968) (426)
- Effects of proteins on thermotropic phase transitions of phospholipid membranes. (1975) (425)
- Membrane fusion and molecular segregation in phospholipid vesicles. (1974) (415)
- Studies on membrane fusion. III. The role of calcium-induced phase changes. (1977) (410)
- Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma. (1996) (382)
- Introduction of liposome-encapsulated SV40 DNA into cells. (1980) (382)
- Endocytosis of liposomes and intracellular fate of encapsulated molecules: Encounter with a low pH compartment after internalization in coated vesicles (1983) (379)
- Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes. (1996) (363)
- Phospholipid model membranes. II. Permeability properties of hydrated liquid crystals. (1967) (358)
- Phospholipid requirements for (Na + + K + )-ATPase activity: head-group specificity and fatty acid fluidity. (1972) (335)
- Tumor targeting using anti-her2 immunoliposomes. (2001) (334)
- Medical applications of liposomes (1998) (328)
- Stabilization of cationic liposome‐plasmid DNA complexes by polyamines and poly(ethylene glycol)‐phospholipid conjugates for efficient in vivo gene delivery (1997) (326)
- Permeability properties of phospholipid membranes: effect of cholesterol and temperature. (1972) (320)
- Role of cholesterol in membranes. Effects on phospholipid-protein interactions, membrane permeability and enzymatic activity. (1973) (319)
- Effects of local anesthetics on membrane properties. I. Changes in the fluidity of phospholipid bilayers. (1975) (313)
- Microscopic localization of sterically stabilized liposomes in colon carcinoma-bearing mice. (1992) (311)
- Studies on membrane fusion. II. Induction of fusion in pure phospholipid membranes by calcium ions and other divalent metals. (1976) (297)
- Irreversible coupling of immunoglobulin fragments to preformed vesicles. An improved method for liposome targeting. (1982) (292)
- Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma. (1992) (288)
- Thermosensitive liposomes: extravasation and release of contents in tumor microvascular networks. (1996) (281)
- The role of surface charge and hydrophilic groups on liposome clearance in vivo. (1992) (262)
- Studies on the mechanism of action of local anesthetics with phospholipid model membranes. (1972) (258)
- Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: biodistribution and imaging studies. (1990) (257)
- Lateral diffusion in phospholipid multibilayers measured by fluorescence recovery after photobleaching. (1977) (257)
- Studies on the mechanism of membrane fusion. Role of head-group composition in calcium- and magnesium-induced fusion of mixed phospholipid vesicles. (1981) (246)
- Recognition of liposomes by cells: in vitro binding and endocytosis mediated by specific lipid headgroups and surface charge density. (1992) (246)
- Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes. (1992) (245)
- Calcium/magnesium specificity in membrane fusion: kinetics of aggregation and fusion of phosphatidylserine vesicles and the role of bilayer curvature. (1981) (238)
- pH‐sensitive liposomes mediate cytoplasmic delivery of encapsulated macromolecules (1985) (233)
- Fusion of mammalian cells by unilamellar lipid vesicles: inflluence of lipid surface charge, fluidity and cholesterol. (1973) (226)
- Ca2+-induced fusion of phospholipid vesicles monitored by mixing of aqueous contents (1979) (220)
- Membrane action of DMSO and other chemical inducers of Friend leukaemic cell differentiation (1976) (220)
- Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long circulation times. (1989) (216)
- Cationic Liposomes Coated with Polyethylene Glycol As Carriers for Oligonucleotides* (1998) (204)
- Liposomes with detachable polymer coating: destabilization and fusion of dioleoylphosphatidylethanolamine vesicles triggered by cleavage of surface‐grafted poly(ethylene glycol) (1996) (204)
- Molecular mechanisms of calcium-induced membrane fusion (1990) (201)
- Specificity of Ca2+ and Mg2+ binding to phosphatidylserine vesicles and resultant phase changes of bilayer membrane structure. (1978) (199)
- Liposomes and hyperthermia in mice: increased tumor uptake and therapeutic efficacy of doxorubicin in sterically stabilized liposomes. (1994) (198)
- Immunospecific targeting of liposomes to cells: a novel and efficient method for covalent attachment of Fab' fragments via disulfide bonds. (1981) (198)
- Quantitative analysis of liposome-cell interactions in vitro: rate constants of binding and endocytosis with suspension and adherent J774 cells and human monocytes. (1993) (197)
- Proton-induced fusion of oleic acid-phosphatidylethanolamine liposomes. (1985) (195)
- Endocytosis of liposomes by macrophages: binding, acidification and leakage of liposomes monitored by a new fluorescence assay. (1990) (190)
- Lipid vesicles as carriers for introducing materials into cultured cells: influence of vesicle lipid composition on mechanism(s) of vesicle incorporation into cells. (1976) (180)
- Liposomes revisited (1995) (179)
- Thermosensitive Sterically Stabilized Liposomes: Formulation and in Vitro Studies on Mechanism of Doxorubicin Release by Bovine Serum and Human Plasma (1995) (178)
- Local anesthetics affect transmembrane cytoskeletal control of mobility and distribution of cell surface receptors. (1975) (174)
- Liposome-mediated delivery of deoxyribonucleic acid to cells: enhanced efficiency of delivery related to lipid composition and incubation conditions. (1981) (171)
- Microvascular studies on the origins of perfusion-limited hypoxia. (1996) (170)
- Studies on membrane fusion. I. Interactions of pure phospholipid membranes and the effect of myristic acid, lysolecithin, proteins and dimethylsulfoxide. (1976) (166)
- Phospholipid-protein interactions: membrane permeability correlated with monolayer "penetration". (1971) (160)
- Covalent attachment of immunoglobulins to liposomes via glycosphingolipids. (1981) (157)
- Interactions of basic proteins with phospholipid membranes. Binding and changes in the sodium permeability of phosphatidylserine vesicles. (1971) (157)
- Phospholipid vesicles (liposomes) as models for biological membranes: Their properties and interactions with cholesterol and proteins (1974) (151)
- Incorporation of lipid vesicles by mammalian cells provides a potential method for modifying cell behaviour (1974) (148)
- [9] Liposome preparation and size characterization (1989) (144)
- Endocytosis and intracellular fate of liposomes using pyranine as a probe. (1990) (138)
- Lipid mixing during membrane aggregation and fusion: why fusion assays disagree. (1987) (135)
- Cellular uptake of cyclic AMP captured within phospholipid vesicles and effect on cell-growth behaviour. (1974) (135)
- Sterically stabilized liposomes. Reduction in electrophoretic mobility but not electrostatic surface potential. (1992) (134)
- OBSERVATIONS ON THE INTERACTION OF PHOSPHOLIPIDS AND CERTAIN CLOTTING FACTORS IN PROTHROMBIN ACTIVATOR FORMATION. (1964) (132)
- Physicochemical characterization of large unilamellar phospholipid vesicles prepared by reverse-phase evaporation. (1983) (131)
- Extravasation and transcytosis of liposomes in Kaposi's sarcoma-like dermal lesions of transgenic mice bearing the HIV tat gene. (1993) (131)
- The use of aqueous space markers to determine the mechanism of interaction between phospholipid vesicles and cells. (1979) (129)
- Lipid vesicles as carriers for introducing biologically active materials into cells. (1976) (129)
- Control of membrane fusion by phospholipid head groups. I. Phosphatidate/phosphatidylinositol specificity. (1981) (128)
- 201 - Binding of Cations to Phosphatidylserine Vesicles (1978) (126)
- Anti-HER2 immunoliposomes for targeted therapy of human tumors. (1997) (126)
- Effects of local anesthetics on membrane properties. II. Enhancement of the susceptibility of mammalian cells to agglutination by plant lectins. (1975) (126)
- Phospholipid model membranes. 3. Antagonistic effects of Ca2+ and local anesthetics on the permeability of phosphatidylserine vesicles. (1970) (121)
- Lipid phase separation induced by a hydrophobic protein in phosphatidylserine--phosphatidylcholine vesicles. (1977) (120)
- Liposomes and their uses in biology and medicine. (1978) (119)
- The effects of liposome size and surface charge on liposome-mediated delivery of methotrexate-gamma-aspartate to cells in vitro. (1985) (119)
- CALCIUM‐INDUCED LIPID PHASE TRANSITIONS AND MEMBRANE FUSION * (1978) (115)
- Studies on Membrane Fusion with Natural and Model Membranes (1979) (113)
- Cholesterol and cell membrane function: a hypothesis concerning etiology of atherosclerosis. (1974) (109)
- Control of membrane fusion by phospholipid head groups. II. The role of phosphatidylethanolamine in mixtures with phosphatidate and phosphatidylinositol. (1981) (106)
- Antibody-targeted liposomes: increase in specific toxicity of methotrexate-gamma-aspartate. (1983) (105)
- Phase separation of acidic and neutral phospholipids induced by human myelin basic protein. (1977) (104)
- Membrane contact, fusion, and hexagonal (HII) transitions in phosphatidylethanolamine liposomes. (1986) (104)
- Modulation of membrane fusion by membrane fluidity: temperature dependence of divalent cation induced fusion of phosphatidylserine vesicles. (1985) (103)
- Ultrastructural characterization of cationic liposome-DNA complexes showing enhanced stability in serum and high transfection activity in vivo. (1998) (103)
- Role of synexin in membrane fusion. Enhancement of calcium-dependent fusion of phospholipid vesicles. (1981) (100)
- The introduction of poliovirus RNA into cells via lipid vesicles (liposomes) (1979) (98)
- Biophysical properties of phospholipids. II. Permeability of phosphatidylserine liquid crystals to univalent ions. (1966) (97)
- Copolymers of N‐isopropylacrylamide can trigger pH sensitivity to stable liposomes (1998) (96)
- Electron diffraction study of hydrated phospholipid single bilayers. Effects of temperature hydration and surface pressure of the "precursor" monolayer. (1975) (95)
- Stability of Asymmetric Phospholipid Membranes (1969) (95)
- Biophysical properties of phospholipids. I. Interaction of phosphatidylserine monolayers with metal ions. (1966) (94)
- Studies on the mechanism of membrane fusion: role of phosphate in promoting calcium ion induced fusion of phospholipid vesicles. (1980) (94)
- Interactions of annexins with membrane phospholipids. (1991) (93)
- Synergistic effects of a membrane protein (spectrin) and Ca 2+ on the Na + permeability of phospholipid vesicles. (1971) (93)
- Inhibition of tumor cell growth in vitro and in vivo by 1-beta-D-arabinofuranosylcytosine entrapped within phospholipid vesicles. (1976) (88)
- Use of lipid vesicles as carriers to introduce actinomycin D into resistant tumor cells. (1976) (87)
- Targeting of Liposomes to Tumor Cells in Vivo a (1987) (83)
- Effects of Bivalent Cations and Proteins on Thermotropic Properties of Phospholipid Membranes: Implications for the Molecular Mechanism of Fusion and Endocytosis (1977) (83)
- Fusion of phospholipid vesicles arrested by quick-freezing. The question of lipidic particles as intermediates in membrane fusion. (1982) (81)
- Fluorescence studies on the mechanism of liposome-cell interactions in vitro. (1980) (79)
- An Improved Method for in Vivo Tracing and Imaging of Liposomes Using a Gallium 67-Deferoxamine Complex (1988) (79)
- Fluorescent probes in model membranes I: anthroyl fatty acid derivatives in monolayers and liposomes of dipalmitoylphosphatidylcholine. (1977) (79)
- Polyamines as modulators of membrane fusion: aggregation and fusion of liposomes. (1983) (79)
- Modulation of membrane fusion by ionotropic and thermotropic phase transitions. (1984) (78)
- Specificity of Na+ binding to phosphatidylserine vesicles from a 23Na NMR relaxation rate study. (1979) (77)
- Liposomes containing colloidal gold are a useful probe of liposome-cell interactions. (1983) (76)
- USE OF LIPOSOMES FOR THE ENHANCEMENT OF THE CYTOTOXIC EFFECTS OF CYTOSINE ARABINOSIDE * (1978) (75)
- Liposome-based therapy of human ovarian cancer: parameters determining potency of negatively charged and antibody-targeted liposomes. (1988) (75)
- Expression of ΔF508 CFTR in normal mouse lung after site-specific modification of CFTR sequences by SFHR (2001) (74)
- Spermine as a modulator of membrane fusion: interactions with acidic phospholipids. (1986) (74)
- Liposome preparation and size characterization. (1989) (73)
- Complex phase mixing of phosphatidylcholine and phosphatidylserine in multilamellar membrane vesicles. (1979) (72)
- Modulation of membrane fusion by calcium-binding proteins. (1982) (71)
- Phospholipid membrane stabilization by dimethylsulfoxide and other inducers of Friend leukemic cell differentiation. (1976) (71)
- Biological properties of poliovirus encapsulated in lipid vesicles: antibody resistance and infectivity in virus-resistant cells. (1977) (71)
- Na + -K + discrimination by "pure" phospholipid membranes. (1971) (71)
- Role of liposome type and route of administration in the antitumor activity of liposome-entrapped 1-beta-D-arabinofuranosylcytosine against mouse L1210 leukemia. (1979) (70)
- Specific enhancement of drug delivery to AKR lymphoma by antibody-targeted small unilamellar vesicles. (1984) (69)
- Retention of cytosine arabinoside in mouse lung following intravenous administration in liposomes of different size. (1979) (67)
- The effect of free fatty acids on the thermotropic phase transition of dimyristoyl glycerophosphocholine. (1978) (66)
- Fluorometric detection of the bilayer-to-hexagonal phase transition in liposomes. (1988) (66)
- Gangliosides reduce leakage of aqueous-space markers from liposomes in the presence of human plasma. (1985) (65)
- Role of cholesterol in enhancing the antitumor activity of cytosine arabinoside entrapped in liposomes. (1979) (65)
- Influence of Surface Charge of Phospholipids on their Clot-Promoting Activity.∗ (1962) (64)
- Targeting of anti-Thy 1.1 monoclonal antibody conjugated liposomes in Thy 1.1 mice after intravenous administration. (1987) (64)
- Role of ligand in antibody-directed endocytosis of liposomes by human T-leukemia cells. (1989) (64)
- Effect of lipid vesicle (liposome) encapsulation of methotrexate on its chemotherapeutic efficacy in solid rodent tumors. (1978) (62)
- Surface properties of phorbol esters and their interaction with lipid monolayers and bilayers. (1975) (60)
- Antagonism of paraoxon intoxication by recombinant phosphotriesterase encapsulated within sterically stabilized liposomes. (1999) (59)
- Synexin facilitates fusion of specific phospholipid membranes at divalent cation concentrations found intracellularly. (1982) (59)
- Liposomes as carriers for intracellular delivery of nucleic acids. (1983) (58)
- Intermembrane contact affects calcium binding to phospholipid vesicles. (1982) (57)
- RETENTION OF AQUEOUS CONTENTS DURING DIVALENT CATION-INDUCED FUSION OF PHOSPHOLIPID-VESICLES (1983) (56)
- Free fatty acid enhancement of cation-induced fusion of liposomes: synergism with synexin and other promoters of vesicle aggregation. (1988) (55)
- Long circulating liposomes encapsulating organophosphorus acid anhydrolase in diisopropylfluorophosphate antagonism. (2000) (54)
- Calcium-induced phase separation and fusion in phospholipid membranes. (1975) (53)
- Local anaesthetics increase susceptibility of untransformed cells to agglutination by concanavalin A (1975) (53)
- Liposomes: the development of a new carrier system for introducing nucleic acid into plant and animal cells. (1982) (52)
- Polyamines. Biological modulators of membrane fusion. (1983) (52)
- Liposome-mediated delivery of tobacco mosaic virus RNA into tobacco protoplasts: A sensitive assay for monitoring liposome-protoplast interactions. (1982) (50)
- Synexin enhances the aggregation rate but not the fusion rate of liposomes. (1988) (49)
- Synexin-like proteins from human polymorphonuclear leukocytes. Identification and characterization of granule-aggregating and membrane-fusing activities. (1987) (49)
- Drug-containing lipid vesicles render drug-resistant tumour cells sensitive to actinomycin D (1976) (49)
- Amino groups at the surfaces of phospholipid vesicles. (1969) (49)
- Liposomes and biopolymers in drug and gene delivery (1996) (49)
- The effect of raised pressure of inert gases on phospholipid membranes. (1967) (48)
- THE INFLUENCE OF VESICLE MEMBRANE PROPERTIES ON THE INTERACTION OF LIPID VESICLES WITH CULTURED CELLS (1978) (48)
- Mechanism of protein-induced membrane fusion: fusion of phospholipid vesicles by clathrin associated with its membrane binding and conformational change. (1989) (47)
- Evidence that the scavenger receptor is not involved in the uptake of negatively charged liposomes by cells. (1992) (47)
- PURIFICATION AND PROPERTIES OF BOVINE FACTOR X: MOLECULAR CHANGES DURING ACTIVATION. (1964) (47)
- Liposomes designed to avoid the reticuloendothelial system. (1990) (46)
- Calcium- and magnesium-induced fusion of mixed phosphatidylserine/phosphatidylcholine vesicles: Effect of ion binding (1981) (46)
- Simultaneous Measurement of Liposome Extravasation and Content Release in Tumors (1997) (46)
- Antibody-directed liposomes: comparison of various ligands for association, endocytosis, and drug delivery. (1986) (45)
- INCORPORATION OF MACROMOLECULES WITHIN LARGE UNILAMELLAR VESICLES (LUV) * (1978) (44)
- PURIFICATION AND PROPERTIES OF BOVINE FACTOR V: A CHANGE OF MOLECULAR SIZE DURING BLOOD COAGULATION. (1964) (42)
- Interaction of clathrin with liposomes: pH‐dependent fusion of phospholipid membranes induced by clathrin (1985) (39)
- Comparing therapeutic and prophylactic protection against the lethal effect of paraoxon. (2004) (39)
- Effect of a phase transition on the binding of 1-anilino-8-naphthalenesulfonate to phospholipid membranes. (1976) (38)
- Studies on model membranes. I. Effects of Ca2+ and antibiotics on permeability of cardiolipin liquid-crystalline vesicles. (1970) (38)
- Simultaneous interaction of monoclonal antibody-targeted liposomes with two receptors on K562 cells. (1983) (38)
- Distribution of liposome-entrapped cations in tumor-bearing mice. (1975) (38)
- A model for the study of the oral administration of peptide hormones. (1979) (37)
- Antibody-directed liposomes. Determination of affinity constants for soluble and liposome-bound antifluorescein. (1984) (35)
- Binding of Ca2+ and Mg2+ to phosphatidylserine vesicles: different effects on P-31 NMR shifts and relaxation times. (1979) (34)
- Conjugation of apolipoprotein B with liposomes and targeting to cells in culture. (1993) (33)
- 5‐Fluoroorotate: a new liposome‐dependent cytotoxic agent (1985) (33)
- Targeting of Liposomes to Solid Tumors: The Case of Sterically Stabilized Anti-Her2 Immunoliposomes (1997) (32)
- Increased liposome extravasation in selected tissues: effect of substance P. (1996) (32)
- Antibody-directed targeting of liposomes to human cell lines: role of binding and internalization on growth inhibition. (1987) (32)
- Light microscopic localization of silver-enhanced liposome-entrapped colloidal gold in mouse tissues. (1991) (30)
- CHAPTER 7 – Ionotropic Effects on Phospholipid Membranes: Calcium/Magnesium Specificity in Binding, Fluidity, and Fusion1 (1983) (28)
- In vitro studies on sterically stabilized liposomes (SL) as enzyme carriers in organophosphorus (OP) antagonism. (2000) (28)
- Anti-HER 2 Immunoliposomes : Enhanced Efficacy Attributable to Targeted Delivery 1 (2002) (27)
- Liposome-mediated delivery of pteridine antifolates to cells in vitro: potency of methotrexate, and its α and γ substituents (1986) (25)
- Anti‐HER2 Immunoliposomes for Targeted Drug Delivery (1999) (24)
- New generation liposomes: the engineering of an efficient vehicle for intracellular delivery of nucleic acids (1981) (24)
- The exothermic reaction of calcium with unilamellar phosphatidylserine vesicles (1981) (22)
- Chapter 24 Liposomes as Drug Carriers (1979) (21)
- Cellular uptake and protection against virus infection by polyinosinic-polycytidylic acid entrapped within phospholipid vesicles. (1977) (21)
- Liquid diffraction analysis of the model membrane system. Egg lecithin + myelin protein (N-2). (1979) (21)
- Asymmetric Phospholipid Membranes: Effect of pH and Ca2+ (1970) (20)
- Fate of Liposomes In Vivo: A Brief Introductory Review (1996) (20)
- Cytotoxicity of antibody-directed liposomes that recognize two receptors on K562 cells. (1984) (19)
- Anti-HER2 Immunoliposomes (2002) (19)
- Interaction of mitochondrial malate dehydrogenase monomer with phospholipid vesicles. (1979) (19)
- Fusion of Phospholipid Vesicles Induced by Divalent Cations and Protons (1987) (18)
- On the Molecular Mechanism of Steric Stabilization of Liposomes in Biological Fluids (1992) (18)
- Targeting of Drugs to Solid Tumors Using Anti-Her2 Immunoliposomes (1998) (18)
- Identification of a potential artifact in the use of electron microscope autoradiography to localize saturated phospholipids in cells. (1978) (17)
- The interaction of phospholipid vesicles with mammalian cells in vitro. (1975) (15)
- Fusion of mammalian cells by lipid vesicles. (1976) (15)
- Control of Membrane Fusion by Divalent Cations, Phospholipid Head-Groups and Proteins (1985) (15)
- 5 – Phospholipid Membranes as Experimental Models for Biological Membranes (1973) (15)
- Endocytosis of Liposomes and Intracellular Fate of Encapsulated Molecules: Strategies for Enhanced Cytoplasmic Delivery (1984) (13)
- Interactions of phospholipids with coagulation factors. (1965) (12)
- CHAPTER 6.1 – Other applications (1998) (12)
- Antibody-directed liposomes: the development of a cell-specific cytotoxic agent. (1984) (11)
- THE ENCAPSULATION OF PICORNAVIRUSES BY LIPID VESICLES: PHYSICAL AND BIOLOGICAL PROPERTIES * (1978) (11)
- Liposome formation and properties: an evolutionary profile. (1988) (10)
- Characterization of a cyclosporine-containing liposome. (1991) (9)
- Development of Liposomes as an Efficient Carrier System: New Methodology for Cell Targeting and Intracellular Delivery of Drugs and DNA (1982) (9)
- Why Fusion Assays Disagree (1988) (9)
- CHAPTER 4.7 – Targeting of sterically stabilized liposomes to cancers overexpressing HER2/neu proto-oncogene (1998) (9)
- Human polymorphonuclear leukocytes contain synexin, a calcium-binding protein that mediates membrane fusion. (1986) (8)
- Protein Modulation of Liposome Fusion (1987) (8)
- Calcium-Induced Membrane Fusion: From Liposomes to Cellular Membranes (1988) (8)
- Conditions of Stability for Liquid-Crystalline Phospholipid Membranes (1970) (7)
- A new Perspective on Liposomes (1992) (7)
- Increased binding of liposomes to cells by electric treatment. (1991) (7)
- Monolayer coupling in phosphatidylserine bilayers: distinct phase transitions induced by magnesium interacting with one or both monolayers. (1988) (6)
- 30-Year Progress for Liposomes: From Serendipity to Molecular Design (1995) (6)
- Liposomes as Macromolecular Carriers for the Introduction of RNA and DNA into Cells (1980) (5)
- Oligonucleotide Pharmacology and Formulation: G3139 Anti-BCL2 Phosphorothioate In Stealth® Liposomes and Gel Implants (1997) (5)
- Gene therapy: Liposomes and gene delivery–a perspective (1998) (4)
- Liposome-mediated delivery of pteridine antifolates to cells in vitro: potency of methotrexate, and its alpha and gamma substituents. (1986) (4)
- A Personal View of Liposomes: From Membrane Modeling to Drug Delivery (1986) (4)
- Roleof LiposomeType and Routeof Administrationin the Antitumor Activityof Liposome-entrapped I -fJ-D-arabinofuranosylcytosine againstMouse L1210Leukemia1 (1979) (4)
- ROLE OF IONIC ENVIRONMENT ON SELF-ASSEMBLY PROPERTIES OF PHOSPHOLIPID MEMBRANES (1978) (4)
- Bilayer Lipid Membranes (BLM): Theory and Practice By H. Ti Tien (review) (2015) (3)
- Interaction of a purified hydrophobic protein from myelin with phospholipid membranes: Studies on ultrastructure, phase transitions and permeability (2005) (3)
- STUDIES ON THE BINDING OF SYNEXIN TO PHOSPHOLIPID VESICLES11Supported by grant no. GM-28117 from the National Institutes of Health, the UCSF Academic Senate (K.H.) and the Arthritis Foundation (P.M.). (1987) (3)
- Liposome Targeting to Tumor Cells in Vivo (1990) (3)
- CHAPTER 1.1 – General introduction (1998) (3)
- INTRODUCTORY REMARKS (1978) (2)
- Inhibition of Tracheal Vascular Extravasation by Liposome-Encapsulated Albuterol in Rats (1998) (2)
- Inhibitionof Tumor Cell Growthin Vitro and in Vivoby 1-@3.D- Arabinofuranosylcytosine EntrappedwithinPhospholipidVesicles1 (1976) (2)
- Drug-containing lipid vesicles render drug-resistant cell sensitive to actinomycin D. (1976) (2)
- Interaction of liposomes with cells in vitro (1995) (2)
- Ultrastructural Morphology of Cationic Liposome/Dna Complexes for Gene Therapy: Correlation to Transfection Activity (1999) (2)
- Sterically Stabilized Immunoliposomes: Formulations for Delivery of Drugs and Genes to Tumor Cells in Vivo (1998) (2)
- Commentary: The Rationale for an International Liposome Society (1998) (1)
- Sterically Stabilized Liposomes as Drug Carriers: Pharmacokinetics, Tissue Distribution and Therapeutic Effects in Tumour-Bearing Mice (1992) (1)
- Cationic Liposome-DNA Complexes: Polymorphism versus Transfection Activity (2000) (1)
- Steric Stabilization of Cationic Liposome-DNA Complexes: Influence on Morphology and Transfection Activity (1998) (1)
- THE USE OF LIPID VESICLES FOR INTRODUCING MACROMOLECULES INTO CELLS (1978) (1)
- pH-Sensitive Liposomes (2019) (0)
- Preparation of stable formulations of lipid-nucleic acid complexes for effective in-vivo administration (1997) (0)
- Liposomes reagissant aux thiols (1982) (0)
- The role of calcium and acidic phospho lipids in membrane fusion a contact induced local phase transition as a key event in membrane fusion phenomena (1980) (0)
- Methods for design of protein-bound lipid microparticles and connections so (1999) (0)
- Antibody-Targeted Liposomes: Development of a Cell-Specific Drug Delivery System (1984) (0)
- Methods for forming lipidic microparticles proteins bound, and their compositions. (1999) (0)
- Oligonucleotide therapeutics: lessons from sterically stabilized liposomes (1997) (0)
- Liposome-Mediated DNA Transfer (1982) (0)
- Delivery of N-(Phosphonacetyl)-L-aspartic acid encapsulated in thermosensitive sterically stabilized liposomes into cultured KB cells via folate receptor (2000) (0)
- Fusion of Liposomes Induced and Modulated by Proteins and Polypeptides (2019) (0)
- In vitro cytotoxicity of cytosine arabinoside entrapped in phospholipid vesicles. Abstr. (1977) (0)
- The use of liposomes in the search for an understanding of the significance of membrane lipid diversity (2009) (0)
- Intermembrane contact affects calk phospholipid vesicles (phosphatidylserine/liposomes/aggregation/fusion) (2016) (0)
- Activated liposomes, method of producing them and protein coupling method using them (1981) (0)
- Monoclonal antibodies and immobilized antibodies (1987) (0)
- CHAPTER 9.1 – Future of liposome applications: Serendipity vs. design (1998) (0)
- Ghosh,P.C. and Bachhawat,B.K. 1992. Role of Surface Glycolipids - Natural or Synthetic Origin on the Biodistribution of Liposomes. ibid 2:369. (1993) (0)
- United States Patent ( 19 ) Martin et al . ( 54 ) THIOL REACTIVE LIPOSOMES (2017) (0)
- MODULATION OF DIVALENT CATION-INDUCED MEMBRANE-FUSION BY IONOTROPIC AND THERMOTROPIC PHASE-TRANSITIONS (1983) (0)
- Liposome-Mediated Delivery of Macromolecules into Eukaryotic Cells (1982) (0)
- Changes of renal ATPase enzymes in different types of kidney preservation. (1975) (0)
- RETENTION OF AQUEOUS CONTENTS DURING CA-2+-INDUCED FUSION OF PHOSPHOLIPID-VESICLES (1983) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Demetrios P. Papahadjopoulos?
Demetrios P. Papahadjopoulos is affiliated with the following schools:
